Washington University in St. Louis-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2019

  1. Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: Extended 3.5-year follow up from a pooled analysis

    Haematologica